NMR vs IX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IX Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock) (IX) driven by superior Valuation, Momentum & Technical while NMR counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, NMR trades at 12.7x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus IX at 12.4x Forward P/E and 20.5% operating margin (+2.1% YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against IX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMR | IX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $28.3B | $36.9B | Larger Scale | IX |
| Trailing P/E Ratio Valuation | 11.2x | 6.3x | Lower Multiple | IX |
| Forward P/E Ratio Valuation | 12.7x | 12.4x | Lower Multiple | IX |
| Revenue Growth (YoY) Growth | +17.9% | +2.1% | Higher Growth | NMR |
| Operating Margin (TTM) Profitability | 25.1% | 20.5% | Higher Margin | NMR |
| Net Profit Margin Profitability | 17.1% | 29.7% | Higher Margin | IX |
| Return on Equity (ROE) Capital Efficiency | 11.5% | 19.7% | Higher ROE | IX |
| 52-Week Range Position Momentum | 60% ($7โ$11) | 46% ($25โ$42) | Stronger Trend | NMR |
| Beta / 30D Volatility Risk Regime | 1.03ฮฒ ยท 29% Vol | 0.98ฮฒ ยท 27% Vol | Lower Realized Risk | IX |
| Unified Institutional Score Composite Signal | 44.5 / 100 (HOLD) | 47.5 / 100 (HOLD) | Higher Composite | IX |